CIENCIASMEDICASNEWS: Health News and Information - News Medical - Pharmacy / Pharmacology

viernes, 10 de agosto de 2018

Health News and Information - News Medical - Pharmacy / Pharmacology - Aug 10, 2018 Edition

Health News and Information - News Medical

	August 10, 2018
	Pharmacy / Pharmacology
	The latest pharmacy / pharmacology news from News Medical

The Pharmaceutical & Chemical Industry -Integration & Maintenance

The pharmaceutical and chemical industries are highly regulated due to the health and safety of the public being of major significance. Regulations are a main consideration for automation to assure that the safety considerations and principles have been observed.

Read Full Article Here

			Importance of Pharmacognosy Pharmacognosy forms an important part of pharmaceutical research and development, particularly in the development of synthetic biosimilar drugs.

			Researchers explore influence of dietary nitrate on cognitive function in veterans with GWI Glenn Wylie, DPhil, and Jorge Serrador, PhD, have won an award from the Rutgers Brain Health Institute. The grant funds a collaborative study between the Department of Pharmacology, Physiology, and Neuroscience at Rutgers New Jersey Medical School and Kessler Foundation.

	Pharmacology of CAR-T Cells Chimeric antigen receptor (CAR)-T cells are T cells which are genetically modified by the addition of tumor-reactive chimeric antigen receptors (CARs). The T cells are the workhorses of the immune system.

	Experts describe role of quantitative systems pharmacology in first-in-human clinical trials Certara, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, announced today that Clinical Pharmacology & Therapeutics has published its "Letter to the Editor" describing the important role that quantitative systems pharmacology can play in defining dosing criteria for first-in-human clinical trials, together with the European Medicines Agency's response.

	AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia AbbVie, a research-based global biopharmaceutical company, today announced it submitted a supplemental New Drug Application to the U.S. Food and Drug Administration for venetoclax in combination with a hypomethylating agent or in combination with low-dose cytarabine for the treatment of newly diagnosed patients with acute myeloid leukemia who are ineligible for intensive chemotherapy.

	Ketamine may be potential therapeutic option for adolescents with treatment-resistant depression A new study has shown a significant average decrease in the Children's Depression Rating Scale among adolescents with treatment-resistant depression who were treated with intravenous ketamine.